Literature DB >> 1431712

Further evidence of benefits of a (non-randomised) breast cancer screening programme: the DOM project.

H J Collette1, F de Waard, J J Rombach, C Collette, N E Day.   

Abstract

STUDY
OBJECTIVE: The aim was to demonstrate the benefits of breast cancer screening on mortality.
DESIGN: The study was an evaluation of a breast cancer screening programme by means of different approaches: (1) a case-control study, breast cancer deaths being the cases; (2) comparing the numbers of breast cancer deaths in screened and unscreened women; (3) comparing breast cancer mortality before and after start of the programme; (4) comparing breast cancer mortality in different large cities; (5) comparing screening activity with mortality reduction.
SETTING: The setting was a breast cancer screening programme in the city of Utrecht, the DOM project, for women aged 50-64 years old at intake, birth cohort 1911-1925. The programme started in 1974, and there were five screening rounds up to 1984. Participation rate in the first round was 72% (14,697 women). MAIN
RESULTS: (1) Screening was protective against dying from breast cancer, odds ratio 0.52, with a stronger effect in older women and no evidence of confounding; (2) risk ratio of dying from breast cancer for women in the response group was the same as the odds ratio, 0.52; (3) breast cancer death rate after the start of the project was nearly 20% lower than before the project started; after correcting for women who could not have benefited from screening the reduction was 33%; (4) a rise in breast cancer mortality in birth cohort 1911-1925 seen in other large cities without a screening programme due to aging of the cohort was not seen in the city of Utrecht; (5) mortality reduction followed the screening activity with a time lag of approximately 5 years.
CONCLUSIONS: Early diagnosis of breast cancer by mammography reduces breast cancer mortality in women 50-64 years old at intake; different approaches to the evaluation of the project give different estimates of the screening effect, making clear that the effect depends on the intensity of the programme.

Entities:  

Mesh:

Year:  1992        PMID: 1431712      PMCID: PMC1059605          DOI: 10.1136/jech.46.4.382

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  14 in total

1.  A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy).

Authors:  D Palli; M R Del Turco; E Buiatti; S Carli; S Ciatto; L Toscani; G Maltoni
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

2.  The role of cervical cytology in the declining morbidity and mortality of cervical cancer.

Authors:  D W Cramer
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

3.  Periodic breast cancer screening in reducing mortality from breast cancer.

Authors:  S Shapiro; P Strax; L Venet
Journal:  JAMA       Date:  1971-03-15       Impact factor: 56.272

4.  [Influence of relative body weight on the prognosis of breast cancer in women].

Authors:  F de Waard; J W van der Velden; M de Does
Journal:  Ned Tijdschr Geneeskd       Date:  1985-03-09

5.  Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.

Authors:  H J Collette; N E Day; J J Rombach; F de Waard
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

Review 6.  Breast cancer screening in women over age 50. A critical appraisal.

Authors:  P H Peeters; A L Verbeek; G A Zielhuis; G P Vooijs; J H Hendriks; M Mravunac
Journal:  Acta Radiol       Date:  1990-05       Impact factor: 1.990

7.  The DOM project for the early detection of breast cancer, Utrecht, The Netherlands.

Authors:  F de Waard; H J Collette; J J Rombach; E A Baanders-van Halewijn; C Honing
Journal:  J Chronic Dis       Date:  1984

8.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

9.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

10.  Body weight and prognosis in breast cancer.

Authors:  N F Boyd; J E Campbell; T Germanson; D B Thomson; D J Sutherland; J W Meakin
Journal:  J Natl Cancer Inst       Date:  1981-10       Impact factor: 13.506

View more
  2 in total

1.  A case control study on the effectiveness of breast cancer screening by clinical breast examination in Japan.

Authors:  S Kanemura; I Tsuji; N Ohuchi; H Takei; T Yokoe; Y Koibuchi; K Ohnuki; A Fukao; S Satomi; S Hisamichi
Journal:  Jpn J Cancer Res       Date:  1999-06

2.  Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom.

Authors:  G A Miltenburg; P H Peeters; J Fracheboud; H J Collette
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.